Personalized immune cells battle tough leukemia in kids and young adults
NCT ID NCT07244406
Summary
This study is testing a new personalized cell therapy for children and young adults (ages 3-25) whose B-cell leukemia has come back or hasn't responded to other treatments. Doctors will collect a patient's own immune cells, modify them in a lab to better target cancer, and then infuse them back. The main goal is to see how well this therapy works and how safe it is for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-ALL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University People's Hospital
RECRUITINGBeijing, China
Contact
Conditions
Explore the condition pages connected to this study.